Fabrinet (FN)
(Delayed Data from NYSE)
$242.85 USD
+8.72 (3.72%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $242.77 -0.08 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$242.85 USD
+8.72 (3.72%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $242.77 -0.08 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet
Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.
Fabrinet (FN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of -1.08% and -0.87%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Fabrinet (FN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fabrinet (FN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Fabrinet (FN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FN vs. NJDCY: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. NJDCY: Which Stock Is the Better Value Option?
Add These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
Debt, which is crucial for most of the companies to finance operations, comes at a cost called interest. Interest expense has a direct bearing on the profits of a company.
4 Stocks With Impressive Interest Coverage Ratio to Invest In
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
Should Value Investors Buy Fabrinet (FN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FN vs. TEL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. TEL: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals
Pick These 4 Stocks With Impressive Interest Coverage Ratio
by Sumit Singh
Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company.
FN vs. TEL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. TEL: Which Stock Is the Better Value Option?
Ballard's (BLDP) Q4 Loss In Line, Revenues Beat Estimates
by Zacks Equity Research
Ballard's (BLDP) fourth-quarter 2019 revenues increase on a year-over-year basis.
Scoop Up These 5 Promising Interest Coverage Ratio Stocks
by Sumit Singh
Interest expense has a direct bearing on the profits of a company and the company's creditworthiness depends on how effectively it meets its interest obligations.
Dull Outlook for Electronics Miscellaneous Components Stocks
by Shalu Saraf
Electronics - Miscellaneous Components stocks are being impacted by trade war tensions. However, strong demand for electronic components are likely to benefit the industry participants.
Is Fabrinet (FN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FN vs. TEL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FN vs. TEL: Which Stock Is the Better Value Option?
Sector ETFs at the Midpoint in Q1: Hits & Misses
by Sanghamitra Saha
The year 2020 has so far been marked with Middle East tensions, the coronavirus outbreak and Wall Street rally. These sector ETFs have come across as winners and losers.
Fabrinet (FN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Fabrinet's (FN) second-quarter fiscal 2020 results benefit from robust revenues from optical communications, industrial lasers and other non-optical applications segments.
Fabrinet (FN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 7.53% and 3.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Fabrinet (FN) Ahead of Earnings?
by Zacks Equity Research
Fabrinet (FN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Fabrinet (FN) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Fabrinet (FN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why the Earnings Surprise Streak Could Continue for Fabrinet (FN)
by Zacks Equity Research
Fabrinet (FN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Fabrinet (FN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 4.88% and 2.29%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?